Natural Capsules: 1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and…
Natural Capsules (NATCAPSUQ) filed a disclosure titled "1. The company is valued at about ₹159 crore.
What happened
Natural Capsules (NATCAPSUQ) filed a disclosure with the exchanges on 13 November 2026 at 07:16 PM titled "1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and Half Yearly ended September, 2026. 2. Approved the Allotment of…".
From the filing: "Approved the Allotment of Securities on ...."
Company snapshot
Natural Capsules is a micro-cap company, with a market value of about ₹159 crore.
The stock last traded at ₹153.1, against a 52-week range of ₹131.2–₹234 (34.6% below the high).
Before this filing the shares had moved −3.5% over the month and −3.8% over three months. Average daily turnover over the last 20 sessions was about ₹0.06 crore.
Promoters held 50.92% at the end of Q1 FY27, down 0.12% points from the previous quarter.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 45 | -5.6 | -5.4 |
| Q2 FY26 | 46 | -7 | -6.76 |
| Q3 FY26 | 38 | -7.1 | -6.88 |
| Q4 FY26 | 58 | -3.4 | -4.82 |
| Q1 FY27 | 49 | -4 | -5.55 |
What history shows
This is not the company's first fund raising disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.4% on average the next trading day and was down 4.7% on average after five days (3 filings with price data).
Market-wide, 1,812 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 2 Sept 2026 | Board Meeting Outcome for Outcome Of The Board Meeting Held On… | +12.7% | −3.5% |
| 1 Jun 2026 | Fund raising | −2.4% | −2.9% |
| 27 May 2026 | Fund raising | −3.2% | −7.5% |
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
- 13 November 2026: Board meeting — Financial Results/Other business matters.
- 13 November 2026: Board meeting — Fund Raising.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.